← FDA Drug Approvals (Drugs@FDA)

TAFLUPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INGENUS PHARMS LLC · Approved 2024-04-05

Drug application

FDA Application #

ANDA218002

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAFLUPROST

Generic name

TAFLUPROST

Active ingredients

TAFLUPROST

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

INGENUS PHARMS LLC

Manufacturer

Ingenus Pharmaceuticals, LLC

First approval

2024-04-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown